191 related articles for article (PubMed ID: 35883147)
1. Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases.
Xie XY; Peng HH; Zhang X; Pan YL; Zhang Z; Cao PG
Radiat Oncol; 2022 Jul; 17(1):132. PubMed ID: 35883147
[TBL] [Abstract][Full Text] [Related]
2. Brain metastases treated with radiosurgery or hypofractionated stereotactic radiotherapy: outcomes and predictors of survival.
Sallabanda M; García-Berrocal MI; Romero J; García-Jarabo V; Expósito MJ; Rincón DF; Zapata I; Magallón MR
Clin Transl Oncol; 2020 Oct; 22(10):1809-1817. PubMed ID: 32124243
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated Stereotactic Radiation Therapy to the Resection Bed for Intracranial Metastases.
Keller A; Doré M; Cebula H; Thillays F; Proust F; Darié I; Martin SA; Delpon G; Lefebvre F; Noël G; Antoni D
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1179-1189. PubMed ID: 28974415
[TBL] [Abstract][Full Text] [Related]
4. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
[TBL] [Abstract][Full Text] [Related]
5. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
6. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of X-ray stereotactic radiotherapy on brain metastases and prognostic analysis.
Wei W; Deng ML; Wu SX; Zeng ZF; Li FY; Wang HY; Bao Y; Gao YH; Chen LX
Chin J Cancer; 2010 Feb; 29(2):202-6. PubMed ID: 20109352
[TBL] [Abstract][Full Text] [Related]
8. Relationship between WBRT total dose, intracranial tumor control, and overall survival in NSCLC patients with brain metastases - a single-center retrospective analysis.
Li Z; Shen D; Zhang J; Zhang J; Yang F; Kong D; Kong J; Zhang A
BMC Cancer; 2019 Nov; 19(1):1104. PubMed ID: 31727054
[TBL] [Abstract][Full Text] [Related]
9. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
10. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Survival of Patients with Brain Metastases According to Prognostic Indexes and Treatment Strategies.
Saginc H; Baltalarli PB; Sagtas E; Coskun ME
Turk Neurosurg; 2020; 30(6):822-831. PubMed ID: 32091122
[TBL] [Abstract][Full Text] [Related]
12. Radiosurgery in the management of brain metastasis: a retrospective single-center study comparing Gamma Knife and LINAC treatment.
Tuleasca C; Negretti L; Faouzi M; Magaddino V; Gevaert T; von Elm E; Levivier M
J Neurosurg; 2018 Feb; 128(2):352-361. PubMed ID: 28338441
[TBL] [Abstract][Full Text] [Related]
13. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionated stereotactic radiotherapy of limited brain metastases: a single-centre individualized treatment approach.
Märtens B; Janssen S; Werner M; Frühauf J; Christiansen H; Bremer M; Steinmann D
BMC Cancer; 2012 Oct; 12():497. PubMed ID: 23098039
[TBL] [Abstract][Full Text] [Related]
15. Prognostic analysis of stereotactic radiosurgery for brain metastases: a single-center retrospective study.
Hao Y; Tang T; Ren J; Li G
Radiol Med; 2023 Oct; 128(10):1271-1283. PubMed ID: 37648956
[TBL] [Abstract][Full Text] [Related]
16. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
17. Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC.
Krämer AS; Adeberg S; Kronsteiner D; König L; Schunn F; Bozorgmehr F; Christopoulos P; Eichkorn T; Schiele A; Hahnemann L; Rieken S; Debus J; Shafie RAE
Clin Lung Cancer; 2023 May; 24(3):269-277. PubMed ID: 36803615
[TBL] [Abstract][Full Text] [Related]
18. Predictors of quality of life and survival following Gamma Knife surgery for lung cancer brain metastases: a prospective study.
Bragstad S; Flatebø M; Natvig GK; Eide GE; Skeie GO; Behbahani M; Pedersen PH; Enger PØ; Skeie BS
J Neurosurg; 2018 Jul; 129(1):71-83. PubMed ID: 28820304
[TBL] [Abstract][Full Text] [Related]
19. Changes in the characteristics of patients treated for brain metastases with repeat stereotactic radiotherapy (SRT): a retrospective study of 184 patients.
Kuntz L; Le Fèvre C; Jarnet D; Keller A; Meyer P; Thiery A; Cebula H; Noel G; Antoni D
Radiat Oncol; 2023 Jan; 18(1):21. PubMed ID: 36717863
[TBL] [Abstract][Full Text] [Related]
20. Radiosurgery for brain metastases: a score index for predicting prognosis.
Weltman E; Salvajoli JV; Brandt RA; de Morais Hanriot R; Prisco FE; Cruz JC; de Oliveira Borges SR; Wajsbrot DB
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1155-61. PubMed ID: 10725626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]